Hematology: Page 4

Video from ASH 2021: Day 1 update

Leah Cepko, a science advisor at Science and Medicine Group, provides an update from the first day of the conference. Click on the video below to view.

December 11, 2021

Study recommends screening for adults at risk of multiple myeloma

By Leah Sherwood

"We know that in cancers such as breast cancer and lung cancer screening, early detection and early intervention can make a difference in patient survival," senior author Dr. Irene Ghobrial of the Dana-Farber Cancer Institute in Boston said in a statement. "We have shown for the first time that with highly sensitive screening techniques, it may eventually be possible to make a difference in the survival of people at elevated risk for multiple myeloma."

December 10, 2021

ASH 2021: What technologies will disrupt hematology diagnostics?

By Leah Sherwood

Changing how clinicians approach medicine

December 10, 2021

AAD secures BARDA contract for early sepsis detection test

By LabPulse.com staff writers

QScout RLD+ can be used in urgent care clinics, doctor's offices, and other nonhospital settings, the company said. It is a rapid hematology analyzer that can describe a seven-part leukocyte differential, including quantifying band neutrophils and other immature granulocytes which can indicate severe infection. Results are available in two minutes compared to the two hours often required by a hospital's testing protocol, according to AAD.

October 5, 2021

Mindray launches new MC-80 cell morphology analyzer

By LabPulse.com staff writers

The company notes that most clinical laboratories must re-examine over 30% of their blood samples. Traditional microscopic review of these samples is labor-intensive and time-consuming, however, according to Mindray.

September 28, 2021

Millions of diabetes blood tests missed during U.K. lockdown

By LabPulse.com staff writers

After extrapolating estimates from six laboratory testing centers across the U.K., researchers determined that approximately 2.5 million diagnostic diabetes blood tests -- an average of 400,000 each month -- were missed or delayed during the six-month lockdown in the U.K. These missed tests resulted in 23,000 missed prediabetes diagnoses and 68,500 missed diabetes diagnoses, according to the EASD.

September 26, 2021

Scopio introduces full-field PBS application

By LabPulse.com staff writers

Designed for hematology labs, the new application features adaptive monolayer identification for analysis. It supports short and long smears, white blood cell detection, preclassification and quantification into 16 classes, red blood cell morphology evaluation from 1,000 fields of view, and automated platelet location and preestimation, the company said.

September 26, 2021

Sysmex America announces CEO's retirement

By LabPulse.com staff writers

Taylor joined the company in 2007 as vice president of marketing. In 2018, he was tapped as the company's CEO.

September 12, 2021

Thermo Fisher announces new suite of assays

By LabPulse.com staff writers

The company said the assays target multiple parts of the B- and T-cell immune receptors using a single reaction with ultrahigh sensitivity, increasing the probability of malignant clone detection and decreasing the time to results.

July 19, 2021

Tempus highlights research results for Tempus xF

By LabPulse.com staff writers

The study, which was published online on July 2 in npj Precision Oncology, found that xF yielded high sensitivity and specificity for calling single-nucleotide variants, insertions/deletions (indels), copy number variants, and gene rearrangement, according to the company.

July 12, 2021

Beckman Coulter unveils new tabletop hematology analyzer

By LabPulse.com staff writers

The DxH 560 AL features auto-loading functionality, as well as closed tube aspiration and walkaway capabilities, according to the company. Users can also continuously add up to 50 samples to the analyzer, which can provide results in 60 sec or less from a sample volume of 17 µL -- less than a drop of blood, Beckman Coulter said.

January 25, 2021

Datar highlights liquid biopsy study results

By LabPulse.com staff writers

The company-sponsored international study included blood samples from more than 30,000 individuals, including thousands of people with 27 types of solid organ cancers. The authors published the results on September 30 in the American Cancer Society's journal Cancer Cytopathology.

November 8, 2020

Previous Page

Page 4 of 7

Next Page